medline.ch Gynäkologie Genitale Erkrankungen

	Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer. Br J Cancer Drew Y, Gilbert L, Martinez Bueno A, Oaknin A, Moreno V, Gaba Garcia L, Jayson GC, Kristeleit RS, Lakhani N, Banerjee S, Matei D, Oza A, Miller R, Yiannakis D, Barretina-Ginesta MP, Martínez García J, Wang G, Miriyala J, Franke A, Galvez E, Pandite L, Richardson DL. PMID: 41951722 [PubMed - as supplied by publisher]
	Role of soluble EGFR, Fas, and Fas ligand in pelvic pain severity and their association with endometriosis in infertile woman: a case-control study. Growth Factors Ahsan F, Rahmawati NY, Alditia FN, Mufid AF, Sa'adi A, Dwiningsih SR, Widyanugraha MYA, Tunjungseto A, Santoso B. PMID: 41951405 [PubMed - as supplied by publisher]
	Updates in Skin Adnexal Tumors. Dermatol Clin Harms PW, Chan MP, Brenn T. PMID: 41951323 [PubMed - indexed for MEDLINE]
	Squamous Precursor Lesions of the Vulva: A Practical Approach. Dermatol Clin Crimmins J, Schneider MM, Selim MA. PMID: 41951322 [PubMed - indexed for MEDLINE]
	Addressing unmet needs in long-term survivors of ovarian cancer (ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI): insights from a Spanish cohort. Int J Gynecol Cancer Barretina-Ginesta MP, Madariaga A, Gil-Martín M, Ramchandani A, Pardo M, Sanchez-Heras AB, Churruca C, Guerra-Alia EM, Madroñal C, Fernandez-Plana J, Herrero A, Dotor E, Esteban C, Quindós-Varela M, Romeo M, Gost E, Bermejo MJ, Fernandez-Chacón C, Ferrer N, Gomez-Raposo C, Tort SC, Eichbaum M, Sehouli J, Woopen H. PMID: 41951282 [PubMed - indexed for MEDLINE]
	Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review. Int J Gynecol Cancer Pareja R, Agustí N, Vieira S, Mora-Soto N, Sanchez E, Fernandes A, Aristizábal B, Heredia F, Levin G, Varon ML, Pontremoli Salcedo M, Krause KJ, Abu-Rustum NR, Huh W, Rauh-Hain JA, Viveros-Carreño D. PMID: 41951281 [PubMed - indexed for MEDLINE]
	Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49). Eur J Cancer Colombo N, Parma G, Tasca G, Di Palma MP, Tognon G, Lissoni AA, Fossati R, Carlucci L, Zucchetti M, Matteo C, Ferrero A, Bologna A, Mantiero M, Wimberger P, Katsaros D, Tomao F, Galli F, Lapresa M, Guarneri V, Ficarelli S, Canova S, Derio S, Girardi F, Zizioli V, Katrini J, Massa D, Rulli E, Biagioli E, NEWTON study group. PMID: 41950571 [PubMed - as supplied by publisher]
	Impact of obesity on surgical outcomes following uterine-preserving apical prolapse repair: A retrospective cohort study. Eur J Obstet Gynecol Reprod Biol Cohen A, Dalyahu Y, Zilberman T, Karavani G, Shekel E, Shveiky D, Chill HH. PMID: 41950545 [PubMed - as supplied by publisher]
	Letrozole for Ovulation Induction in Women With Polycystic Ovary Syndrome. Obstet Gynecol Surv Li XL. PMID: 41950500 [PubMed - indexed for MEDLINE]
	C5 Subcutaneous Fat Thickness Ratio Predicts Surgical Site Infection After Cervical Laminoplasty: A Propensity Score-Matched Study. Global Spine J Wu Y, Xu S, Liang Y, Zhang C, Li H, Zhang J, Zhu J, Zhang H, Liu H, Wang K. PMID: 41949911 [PubMed - as supplied by publisher]
	Cervical spinal cord enlargement and systemic inflammation in diabetic peripheral neuropathy: a cross-sectional MRI study. Ir J Med Sci Ta, Ta, Atik , Ba, Apalan D, Sabancio. PMID: 41949694 [PubMed - as supplied by publisher]
	Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin-releasing hormone (GnRH) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) and retained products of conception (RPOC): A retrospective cohort study. Int J Gynaecol Obstet Foroughi AA, Dehghani SS, Shiravani Z, Mansoori M. PMID: 41949559 [PubMed - as supplied by publisher]
	Addressing Inequalities in Cervical Cancer Screening: Nursing Strategies to Overcome Barriers and Improve Health Outcomes. Clin J Oncol Nurs Richards-McDonald L, Baptiste DL, Nettles B. PMID: 41949349 [PubMed - indexed for MEDLINE]
	History of Infertility and Plasma Markers of Inflammation, Cholesterol, and Adipokines Among Participants in the Nurses' Health Study II. J Womens Health (Larchmt) Farland LV, Degnan WJ 3rd, Wang S, Gaskins AJ, Chavarro JE, Rich-Edwards JW, Missmer SA. PMID: 41948875 [PubMed - indexed for MEDLINE]
	Integrative molecular diagnostics for HPV-driven cervical carcinogenesis: a translational review of mechanisms and multimodal risk stratification. Front Oncol Fallatah DI, Adekola HA. PMID: 41948494 [PubMed]
	Integrating reproductive and metabolic factors for uterine fibroid risk assessment: a two-center machine learning study with SHAP interpretability. Front Oncol Ji Y, Shen Y, Wu Y, Lei K, Kang M, Wang J. PMID: 41948489 [PubMed]
	S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancer. Ther Adv Med Oncol Maimaiti Y, Chen Y, Li L, Cai M, Li Z, Lin L, Gao S, Zhuang G, Wu W, Zang R. PMID: 41948466 [PubMed]
	From models to medicine: systematic development and evaluation of animal models for Chlamydia psittaci respiratory and genital tract infections. Front Immunol Zhang J, Wu H, Li Y, Wang C. PMID: 41948330 [PubMed - indexed for MEDLINE]
	Effectiveness of Specific Hormonal Protocols on Uterine Involution and Ovarian Cyclicity in Early Postpartum Egyptian Buffaloes. Vet Med Int Salama MS, Ashour MA, Abdulkarim A, Shukry M, Metwally AS, Abusaeda I, Khesruf KA, Khalphallah A, El-Hamd MAA. PMID: 41948309 [PubMed]
	Metastatic High-Grade Serous Ovarian Carcinoma Presenting as a Temporal Lobe Glioblastoma Mimic: A Diagnostic Pitfall. Cureus Sravya M, Venkata Renuka I, Tejeswini V, Boddapati A, Katragadda N. PMID: 41948274 [PubMed]

Artikel 1 - 20 / 285520

Seite 1 von 14276

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung